We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




G Proteins Recognized as Critical Modulators of Thyroid Function

By Biotechdaily staff writers
Posted on 21 Aug 2007
Researchers working with a line of mice genetically engineered to lack the alpha subunits of the G proteins Gq and G11 have found that these animals had reduced thyroid gland function and in many cases displayed symptoms similar to individuals with hypothyroidism. More...


G proteins, short for guanine nucleotide binding proteins, are a family of proteins involved in second messenger cascades. Their signaling mechanism uses the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) as a general molecular "switch” function to regulate cell processes. The name G protein usually refers to the membrane-associated heterotrimeric G proteins, sometimes referred to as the large G proteins. These proteins are activated by G protein-coupled receptors and are made up of alpha, beta, and gamma subunits. There are also small G proteins that are monomeric, but also bind GTP and GDP and are involved in signal transduction.

Investigators at the University of Heidelberg (Germany; www.uni-heidelberg.de) genetically engineered a line of mice to lack the alpha subunits in both the Gq and G11 proteins present in the animal's thyroid tissues. They reported in the August 9, 2007, online edition of the Journal of Clinical Investigation that these mice showed severely reduced iodine organification and thyroid hormone secretion in response to TSH, and many developed hypothyroidism within months after birth. In addition, thyrocyte-specific Gq/G11-deficient mice lacked the normal proliferative thyroid response to TSH or goitrogenic diet, indicating an essential role of this pathway in the adaptive growth of the thyroid gland.

The authors concluded, "Our data suggest that Gq/G11 and their downstream effectors are promising targets to interfere with increased thyroid function and growth.” Drugs to this effect would be of therapeutic benefit for individuals with diseases characterized by increased thyroid gland function and/or growth.


Related Links:
University of Heidelberg

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Analyzer
respons® UDS100
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.